Back to Treatments

Treatment

ARNI (Sacubitril/Valsartan)

1
Conditions
1
Trials
25K
Participants
65%
Average Safety

Condition Evidence

Dilated Cardiomyopathy

1 trials · 25K participants

90% effectiveness · 65% safety
ARNI (Sacubitril/Valsartan) | DFDA